Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis

被引：5
|
作者：
Brannigan, Jamie [1 ]
Jones, Joanne L. [2 ]
Stacpoole, Sybil R. L. [1 ,2 ,3 ]
机构：
[1] Univ Cambridge, Jesus Coll, Cambridge CB2 1TN, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Neurol, Cambridge, England
[3] North West Anglia NHS Fdn Trust, Peterborough City Hosp, Dept Neurol, Peterborough, Cambs, England
来源：
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION | 2020年 / 7卷 / 05期
基金：
英国惠康基金;
关键词：
D O I：
10.1212/NXI.0000000000000799
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A 39-year-old right-handed agricultural service engineer developed rapidly evolving severe relapsing-remitting multiple sclerosis (MS). MRI showed multiple T2 hyperintensities throughout his neuroaxis (figure, A). Several lesions showed restricted diffusion, and 2 enhanced. He received steroids for each relapse, making a full recovery (Expanded Disability Status Score [EDSS] 0).
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis
    Alamo, Angela
    Condorelli, Rosita A.
    La Vignera, Sandro
    Calogero, Aldo E.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2019, 33
  • [2] Behcet's disease following alemtuzumab treatment for multiple sclerosis
    Luppe, S.
    Wright, B.
    Angus, J.
    Ormerod, E.
    Inglis, K.
    Cottrell, D.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 920 - 920
  • [3] Sarcoidosis following alemtuzumab treatment for multiple sclerosis
    Willis, Mark D.
    Hope-Gill, Ben
    Flood-Page, Patrick
    Joseph, Fady
    Needham, Ed
    Jones, Joanne
    Coles, Alasdair
    Robertson, Neil P.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (13) : 1779 - 1782
  • [4] Melanoma following treatment with alemtuzumab for multiple sclerosis
    Pace, A. A.
    Zajicek, J. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (04) : E70 - E71
  • [5] SARCOIDOSIS FOLLOWING ALEMTUZUMAB TREATMENT FOR MULTIPLE SCLEROSIS
    Willis, M. D.
    May, K.
    Hope-Gill, B.
    Flood-Page, P.
    Jeffrey, D.
    Joseph, F.
    Robertson, N. P.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A54 - A55
  • [6] HYPERSENSITIVITY PNEUMONITIS FOLLOWING ALEMTUZUMAB TREATMENT FOR MULTIPLE SCLEROSIS
    Willis, Mark
    Cossburn, Mark
    Ingram, Gillian
    Pickersgill, Trevor
    Barry, Simon
    Robertson, Neil
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
  • [7] Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis
    Giarola, Blake
    Massey, Jennifer
    Barnett, Yael
    Rodrigues, Michael
    Sutton, Ian
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 28 : 31 - 33
  • [8] Predicting Autoimmunity Following Treatment of Multiple Sclerosis with Alemtuzumab
    Jones, Joanne
    Compston, Alastair
    Coles, Alasdair
    CLINICAL IMMUNOLOGY, 2010, 135 : S103 - S103
  • [9] Predicting autoimmunity following treatment of multiple sclerosis with alemtuzumab
    Jones, J. L.
    Compston, D. A. S.
    Coles, A. J.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S459 - S459
  • [10] A case of severe Legionella pneumonia following alemtuzumab infusion for multiple sclerosis
    Spurgeon, Elizabeth N.
    Abbatemarco, Justin R.
    Miranda, Cyndee
    Rensel, Mary R.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 196
12345